Boyan Litchev
Career history of Boyan Litchev
Former positions of Boyan Litchev
| Companies | Position | Start | End |
|---|---|---|---|
| AKCEA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Corporate Officer/Principal | 31/12/2020 | - |
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
| INDAPTUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/01/2022 | - |
Training of Boyan Litchev
| Medical University of Plovdiv | Doctorate Degree |
Statistics
International
| United States | 6 |
| Bulgaria | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| INDAPTUS THERAPEUTICS, INC. | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Health Technology |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Boyan Litchev
- Experience
